Updated
Updated · The Motley Fool · Aug 8
Oklo Posts $48.5 Million Q2 Loss on $1.2 Million Revenue as Nuclear Timelines Reprice
Updated
Updated · The Motley Fool · Aug 8

Oklo Posts $48.5 Million Q2 Loss on $1.2 Million Revenue as Nuclear Timelines Reprice

1 articles · Updated · The Motley Fool · Aug 8

Summary

  • $1.2 million in second-quarter revenue marked Oklo’s first meaningful sales, but the advanced-reactor developer’s net loss widened to $48.5 million from $33.1 million in the first quarter.
  • $3 billion in cash and marketable securities gives Oklo years of funding, yet its Aurora powerhouses are still in development and the company remains pre-commercial.
  • Three reactor developers—Oklo, NuScale and Nano Nuclear—still carry about $12 billion in combined market value despite only roughly $12 million in trailing-12-month revenue.
  • That gap has come under pressure as nuclear growth stocks reprice: Oklo is about 77% below its 52-week high, NuScale 83% below, and Nano Nuclear about 70% down.
  • The sell-off underscores that investors in these names are largely backing cash reserves and regulatory timelines tied to hoped-for AI data-center demand, not established operating businesses.

Insights

Which pre-commercial nuclear developer is secretly closest to turning its cash reserves into a commercial energy empire?
If next-gen reactors face further delays, can fuel producers sustain their massive valuations on supply agreements alone?
Will the market's impatience with advanced reactor timelines ultimately choke off the nuclear renaissance before it begins?